Cipla Q1 Results
- BSE: 500087
- NSE: CIPLA
- ISIN: INE059A01026
- Sector: Biotechnology & Drugs
BSE
1,380
12.00 (0.88%)
12.00 (0.88%)Volume15.54 K
Updated: Thu 10 Sep, 2026 | 15:29:32
NSE
1,373.3010.20 (0.75%)
10.20 (0.75%)Volume8.26 L
Updated: Thu 10 Sep, 2026 | 15:14:59
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q1 Results Highlights
- Total Income₹7,119.28 Cr.(2.33%)
- Operating Profit₹888.06 Cr.(-41.78%)
- Profit After Tax₹789.05 Cr.(-39.19%)
- Operating Margin12.47%(-43.11%)
Note: Comparison is on YoY basis
Quarterly - Cipla Q1 Results
*All figures in crores except per share values
| Fiscal Period | Jun 26 | Mar 26 | QoQ Comp | Jun 24 | YoY Comp |
|---|---|---|---|---|---|
| Total Operating Expense | 6,231.22 | 5,969.17 | 4.39% | 5,224.82 | 14.71% |
| Depreciation/ Amortization | 304.24 | 382.92 | -20.55% | 246.68 | 20.39% |
| Operating Income | 888.06 | 572.03 | 55.25% | 1,469.12 | -41.78% |
| Net Income | 789.05 | 554.64 | 42.26% | 1,177.64 | -39.19% |
| Other Operating Expenses Total | 1,762.39 | 1,881.30 | -6.32% | 1,591.03 | 3.89% |
| Net Income Before Taxes | 1,081.93 | 707.06 | 53.02% | 1,611.36 | -38.87% |
| Total Revenue | 7,119.28 | 6,541.20 | 8.84% | 6,693.94 | 2.33% |
| Selling/ General/ Admin Expenses Total | 1,497.41 | 1,414.25 | 5.88% | 1,194.23 | 14.11% |
| Diluted Normalized EPS | 9.76 | 7.27 | 34.28% | 14.57 | -39.23% |
EQUITY QUICK LINKS
FROM MARKETS
Trending Stocks
✕
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.